Details

Karakterizacija zlitine AlSi7Mg0,3 : diplomsko delo
ID Sovinc, Martina (Author), ID Markoli, Boštjan (Mentor) More about this mentor... This link opens in a new window, ID Ajlec, Tomaž (Comentor)

.pdfPDF - Presentation file, Download (2,44 MB)
MD5: FB3FC3950F42767E9CE81FC1E9884D9E
PID: 20.500.12556/rul/215110df-8d68-4ad0-83dd-526cf2533058

Language:Slovenian
Keywords:aluminijeva zlitina, tlačno litje, mehanske lastnosti, karakterizacija
Work type:Bachelor thesis/paper
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[M. Sovinc]
Year:2017
Number of pages:VI, 37 f.
PID:20.500.12556/RUL-94461 This link opens in a new window
UDC:669.2/.8
COBISS.SI-ID:1666143 This link opens in a new window
Publication date in RUL:29.08.2017
Views:9860
Downloads:718
Metadata:XML DC-XML DC-RDF
:
SOVINC, Martina, 2017, Karakterizacija zlitine AlSi7Mg0,3 : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Sovinc. [Accessed 17 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=94461
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:aluminium alloy, die-casting, mechanical properties, characterization

Similar documents

Similar works from RUL:
  1. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  2. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  3. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  4. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
  5. Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  4. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  5. Neurological adverse events of immune checkpoint inhibitors

Back